Bamco Inc. NY Buys 343,797 Shares of Integer Holdings Corporation $ITGR

Bamco Inc. NY increased its stake in shares of Integer Holdings Corporation (NYSE:ITGR) by 81.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 766,055 shares of the medical equipment provider’s stock after buying an additional 343,797 shares during the period. Bamco Inc. NY’s holdings in Integer were worth $79,156,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Salomon & Ludwin LLC acquired a new stake in Integer during the third quarter worth approximately $26,000. Global Retirement Partners LLC grew its position in shares of Integer by 293.8% in the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 238 shares during the last quarter. MAI Capital Management grew its position in shares of Integer by 220.9% in the second quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 254 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Integer by 210.5% during the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after purchasing an additional 362 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its stake in shares of Integer by 861.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 620 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

Shares of Integer stock opened at $83.06 on Friday. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69. The company has a market cap of $2.86 billion, a PE ratio of 28.94, a price-to-earnings-growth ratio of 1.41 and a beta of 0.75. The company has a 50 day moving average of $85.23 and a 200-day moving average of $85.84. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $127.56.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06. Integer had a net margin of 5.55% and a return on equity of 13.26%. The business had revenue of $472.06 million for the quarter, compared to analysts’ expectations of $462.73 million. During the same period last year, the firm posted $1.43 earnings per share. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. As a group, equities research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ITGR has been the subject of several recent research reports. Truist Financial boosted their price target on Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Friday, February 20th. Wells Fargo & Company lifted their target price on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, February 20th. Wall Street Zen cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, February 24th. Finally, Citigroup lifted their price objective on shares of Integer from $75.00 to $92.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Four equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $102.00.

Trending Headlines about Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Board change and activist cooperation — Integer appointed James Flanagan as an independent director and added Aaron Kapito in connection with a cooperation agreement with Irenic Capital Management; this strengthens governance and signals potential for board‑driven strategic or operational initiatives that investors often view as a catalyst for value realization. Integer Appoints James Flanagan and Aaron Kapito to Board of Directors
• Positive Sentiment: Zacks raises medium‑term outlook — the research team increased FY2027 and FY2028 EPS forecasts (FY2027 to $6.95, FY2028 to $7.57) and upgraded several quarterly estimates (notably Q3 & Q4 2027 and Q4 2026), implying better earnings growth in 2027–2028 versus prior views, which supports a higher valuation longer term. MarketBeat: Zacks Research estimate updates for Integer
• Neutral Sentiment: FY2026 estimate essentially unchanged — Zacks trimmed FY2026 slightly (from $6.41 to $6.40), leaving the company roughly within its guided range; this is unlikely to materially move sentiment by itself. MarketBeat: Zacks Research estimate updates for Integer
• Negative Sentiment: Near‑term cuts to some quarters — Zacks lowered Q1 2026 (to $1.31), Q3 2026 (to $1.73) and Q1 2027 (to $1.51) estimates, which could pressure near‑term guidance expectations and weigh on the stock until upcoming quarterly results confirm or refute these softer projections. MarketBeat: Zacks Research estimate updates for Integer

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.